Main Street Financial Solutions’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-8,017
| Closed | -$63.5K | – | 541 |
|
2024
Q2 | $63.5K | Hold |
8,017
| – | – | 0.01% | 523 |
|
2024
Q1 | $109K | Hold |
8,017
| – | – | 0.01% | 498 |
|
2023
Q4 | $86.7K | Hold |
8,017
| – | – | 0.01% | 441 |
|
2023
Q3 | $52.1K | Hold |
8,017
| – | – | 0.01% | 442 |
|
2023
Q2 | $144K | Hold |
8,017
| – | – | 0.02% | 432 |
|
2023
Q1 | $188K | Hold |
8,017
| – | – | 0.03% | 433 |
|
2022
Q4 | $200K | Hold |
8,017
| – | – | 0.03% | 418 |
|
2022
Q3 | $255K | Hold |
8,017
| – | – | 0.04% | 361 |
|
2022
Q2 | $317K | Hold |
8,017
| – | – | 0.04% | 333 |
|
2022
Q1 | $322K | Hold |
8,017
| – | – | 0.05% | 348 |
|
2021
Q4 | $405K | Hold |
8,017
| – | – | 0.06% | 315 |
|
2021
Q3 | $521K | Hold |
8,017
| – | – | 0.08% | 242 |
|
2021
Q2 | $311K | Hold |
8,017
| – | – | 0.05% | 349 |
|
2021
Q1 | $421K | Hold |
8,017
| – | – | 0.08% | 246 |
|
2020
Q4 | $545K | Buy |
+8,017
| New | +$545K | 0.11% | 188 |
|